Resection of Residual Masses After Chemotherapy for Metastatic Nonseminomatous Germ Cell Tumors in Adolescents and Adults
Journal of Clinical Oncology · 10.08.2023 · 41 (23) · 3899-3904
DOI: 10.1200/jco.23.00654 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Oncology, erschienen am 10.08.2023. Verfasst von Timothy D Gilligan. Beteiligte Einrichtung: Cleveland Clinic Taussig Cancer Institute, Cleveland, OH. Hauptthemen laut MEDLINE: Testicular Neoplasms, Neoplasms, Germ Cell and Embryonal, Teratoma. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 55 Literaturangaben.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Resection of all residual masses after chemotherapy remains the standard of care in testicular nonseminomas.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Cleveland Clinic Taussig Cancer Institute, Cleveland, OH.
ORCID-Profile: Timothy D Gilligan
Zitieren
APA
Gilligan, T. D. (2023). Resection of Residual Masses After Chemotherapy for Metastatic Nonseminomatous Germ Cell Tumors in Adolescents and Adults. Journal of Clinical Oncology, 41(23), 3899-3904. https://doi.org/10.1200/jco.23.00654
Vancouver
Gilligan TD. Resection of Residual Masses After Chemotherapy for Metastatic Nonseminomatous Germ Cell Tumors in Adolescents and Adults. Journal of Clinical Oncology. 2023;41(23):3899-3904. doi:10.1200/jco.23.00654
BibTeX
@article{Gilligan2023,
author = {Gilligan, Timothy D},
title = {Resection of Residual Masses After Chemotherapy for Metastatic Nonseminomatous Germ Cell Tumors in Adolescents and Adults},
journal = {Journal of Clinical Oncology},
year = {2023},
volume = {41},
number = {23},
pages = {3899--3904},
doi = {10.1200/jco.23.00654}
}
EUVIMED